A case of fatal stent thrombosis after Carbostent implantation: Is clopidogrel alone antiplatelet therapy a safe alternative to aspirin alone antiplatelet therapy?

International Journal of Cardiology

Volumn 114, Issue 2, 2007, Pages 279-281

  Niccoli, Giampaolo ^a   Siviglia, Massimo ^a   De Vita, Maria ^a   Altamura, Luca ^a   Fusco, Beatrice ^a   Leone, Antonio Maria ^a   Ferrante, Giuseppe ^a   Rebuzzi, Antonio G ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Carbostent; Clopidogrel; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

AGED; ARTICLE; CASE REPORT; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; DISEASE COURSE; DISEASE SEVERITY; DRUG SAFETY; FATALITY; HEART ARREST; HUMAN; HYPOTENSION; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RECTUM CANCER; ST SEGMENT ELEVATION; THORAX PAIN; THROMBOSIS;

AGED; ASPIRIN; FATAL OUTCOME; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; STENTS; THROMBOSIS; TICLOPIDINE;

EID: 33751240796     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.11.079     Document Type: Article

References (10)

1. Gurbel P.A., O'Connor C.M., Cummings C.C., et al. Clopidogrel: the future choice for preventing platelet activation during coronary stenting?. Pharm Res 65 (1999) 109-123
2. Bartorelli A.L., Trabattoni D., Montorsi P., et al. Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent™: the Antares study. Catheter Cardiovasc Interv 55 (2002) 150-156
3. Mark K.H., Belli G., Ellis S.G., and Moliterno D.J. Subacute stent thrombosis: evolving issues and current concepts. J Am Coll Cardiol 27 (1996) 494-503
4. Honda Y., and Fitzgerald P.J. Stent thrombosis. An issue revisited in a changing world. Circulation 108 (2003) 2-5
5. Leon M.B., Baim D.S., Popma J.J., et al. A clinical trial comparing three antithrombotic drug regimens after coronary artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 339 (1998) 1665-1671
6. Mehran R., Aymong E.D., Ashby D.T., et al. Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study. Circulation 108 9 (2003) 1078-1083
7. Antoniucci D., Bartorelli A., Valenti R., et al. Clinical and angiographic outcome after coronary arterial stenting with the Carbostent. Am J Cardiol 85 (2000) 821-825
8. Wenaweser P., Dorffler-Melly J., Imboden Katja S., et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 45 (2005) 1748-1752
9. Ajzenberg N., Aubry P., Huisse M.G., et al. Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study. J Am Coll Cardiol 45 (2005) 1753-1756
10. Gurbel P.A., Bliden K.P., Hiatt B.L., and O'Connor C.M. Clopidogrel for coronary stenting. Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation (2003) 2908-2913